(Q36166960)

12 August 2017

1 reference

title

GM-CSF gene-transduced tumor vaccines (English)

1 reference

12 August 2017

Robert Eager

1

1 reference

PubMed ID

15963916

12 August 2017

John Nemunaitis

series ordinal

2

1 reference

12 August 2017

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

12

1 reference

12 August 2017

18-27

1 reference

12 August 2017

1

1 reference

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Lung cancer vaccines and gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Model predicting survival in stage I melanoma based on tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

On natural and artificial vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

GM-CSF-based cellular vaccines: a review of the clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Human tumor antigens recognized by T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

New paths in human cancer serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Human neoplasms elicit multiple specific immune responses in the autologous host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Cytokine-secreting tumor cell vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Cytokines in cancer pathogenesis and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Mouse CD1-specific NK1 T cells: development, specificity, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

NKT cells - conductors of tumor immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

GM-CSF-secreting melanoma vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Genetically engineered tumor cell vaccine in a head and neck cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

Detection and characterization of carcinoma cells in the blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.012

10.1016/J.YMTHE.2005.02.012

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15963916